Since the discovery of SARS-CoV-2, three variants of concern (VOC), first identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1), have been
The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) today kicked off a new initiative aimed at strengthening post-marketing
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 April 2021and includes updates on COVID-19, influenza, measles, Ebola virus disease,
The downloadable data file contains information about the volume of COVID-19 sequencing, the number and percentage distribution of variants of concern (VOC) by week and
Europe is at a critical juncture in its fight against COVID-19. Many countries are currently relaxing restrictions, some against a backdrop of increasing numbers of
This document aims to provide interim guidance on the risks for fully vaccinated individuals to develop or transmit infection that will give rise to severe
σύνδεση μεταξύ του εμβολίου και της εμφάνισης θρόμβωσης σε συνδυασμό με θρομβοπενία Αγαπητέ Επαγγελματία Υγείας, Η AstraZeneca AB σε συμφωνία με τον Ευρωπαϊκό Οργανισμό Φαρμάκων